about
Advances in progenitor cell therapy using scaffolding constructs for central nervous system injury.Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children.Effects of ketamine on endotoxin and traumatic brain injury induced cytokine production in the rat.The Congenital Diaphragmatic Hernia Study Group registry update.Medical photography: current technology, evolving issues and legal perspectives.Prevalence and impact of admission hyperfibrinolysis in severely injured pediatric trauma patients.Factors associated with early recurrence after congenital diaphragmatic hernia repair.Prenatally diagnosed congenital diaphragmatic hernia: optimal mode of delivery?Congenital diaphragmatic hernia-associated pulmonary hypertension.Congenital Diaphragmatic Hernia Defect Size and Infant Morbidity at Discharge.Laboratory evaluation for pediatric patients with suspected necrotizing soft tissue infections: A case-control study.Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats.Improving gastroschisis outcomes: does birth place matter?Development and Validation of Extracorporeal Membrane Oxygenation Mortality-Risk Models for Congenital Diaphragmatic Hernia.Perturbations in Endothelial Dysfunction-Associated Pathways in the Nitrofen-Induced Congenital Diaphragmatic Hernia Model.Inflammation-Stimulated Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Inflammation.Long-term follow-up of congenital diaphragmatic hernia.Can We Identify Futility In Kids? An Evaluation of Admission Parameters Predicting 100% Mortality in 1292 Severely Injured Children.Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Modify Microglial Response and Improve Clinical Outcomes in Experimental Spinal Cord Injury.Bone marrow-derived stromal cell therapy for traumatic brain injury is neuroprotective via stimulation of non-neurologic organ systems.Outcomes of infants with congenital diaphragmatic hernia treated with venovenous versus venoarterial extracorporeal membrane oxygenation: A propensity score approachPrenatally versus postnatally diagnosed congenital diaphragmatic hernia - Side, stage, and outcomeExtracorporeal Membrane Oxygenation (ECMO) Risk Stratification in Newborns with Congenital Diaphragmatic Hernia (CDH)Telemedicine in pediatric surgeryTrends in Mortality and Risk Characteristics of Congenital Diaphragmatic Hernia Treated With Extracorporeal Membrane OxygenationObstructing colon mass in the setting of intestinal non-rotationClinical features and outcomes associated with tracheostomy in congenital diaphragmatic herniaCongenital diaphragmatic hernia-associated pulmonary hypertensionIntroductionLINE- and Alu-containing genomic instability hotspot at 16q24.1 associated with recurrent and nonrecurrent CNV deletions causative for ACDMPVEstablishing a regional pediatric trauma preventable/potentially preventable death rateA Morphometric Model for Endovascular Occlusion of The Retrohepatic Vena Cava in Pediatric TraumaManagement preferences in ECMO mode for congenital diaphragmatic herniaRapunzel Syndrome: A Rare Case Requiring Surgical Management of Acute PancreatitisCongenital diaphragmatic hernia and associated omphalocele: a study from the CDHSG registryPurinergic Signaling in Pulmonary InflammationPotential survival benefit with repair of congenital diaphragmatic hernia (CDH) after extracorporeal membrane oxygenation (ECMO) in select patients: Study by ELSO CDH Interest GroupA Multicenter Study of Nutritional Adequacy in Neonatal and Pediatric Extracorporeal Life SupportVentricular Dysfunction Is a Critical Determinant of Mortality in Congenital Diaphragmatic HerniaSurgical Repair of Congenital Diaphragmatic Hernia After Extracorporeal Membrane Oxygenation Cannulation: Early Repair Improves Survival
P50
Q33870573-14D67BFF-60F8-459C-8677-E8456AE71722Q35151981-2CA1ACC3-33EA-4FFE-8372-A9500AEACEBFQ36107372-68E4A3E4-8A9B-4BF9-8AD4-48579CD5C082Q38259220-963AFF14-2F0E-49FD-A26A-13C19312EE0FQ38364492-EFCD3EDD-F462-44EF-99F3-5E05D14E1094Q38526750-4CE9AFF6-E869-4AB2-8596-96071125289BQ38866631-B190CD56-9566-4DD4-A4CB-78B01F48B4A1Q39038734-7A7CCCB2-2036-4722-BF66-E0CCB9ABE12EQ39392079-C310AF5E-11F9-4AE3-9BB4-F637BD14312AQ40430283-C7E52C38-797B-48EB-931A-2A2D3FF79239Q40656535-3583B2C9-25CB-435E-937D-2312A9C7416DQ41522029-692A89E7-9DD4-4DDD-8DA3-D1C4488D8E6AQ41714715-0ACB6B42-AB43-4BF4-AAA3-C70C3FF6C6DEQ46119472-4C2B7F7B-359E-4303-BA54-FB751983B86EQ47318983-AF20D0A2-9607-46A7-A3B3-317AFB8AA701Q47596235-E7B62358-C044-4BFD-B5D6-8BF319446870Q47791711-69A9A194-2E9F-499A-96D5-5569084D687AQ47869426-CF68896D-C9D4-479C-9CBF-009E940A09AEQ48262918-8A93E589-844A-431A-A872-91E1C375ECEFQ48421649-8AB38B0D-3888-45DD-9C42-1A33AAD2E7F4Q57455806-A29A521A-BC49-4D09-846A-298BA1E0FE1DQ88649206-3285F062-C2F4-42CF-9C64-E10439E27D77Q88653494-9A56E44E-8E10-4D04-837D-C2093FB05D22Q88865240-AA501D19-BA82-418C-BBFE-3AF5F0805890Q88972426-8727ED41-C0CF-4710-AA0B-BEF07AD213C8Q89426497-ABAD17D3-5B27-47ED-A860-1E94FB690A55Q90014974-52677443-8FA6-4093-B61E-9BDC7896828EQ90099001-08C01A63-DA54-4F01-A664-57EB0D35CF00Q90099006-922C72C4-9E77-497E-A5B1-9B4B26F70006Q90798404-8F07CC0B-63FF-43B9-AE35-AD1585F26541Q91180046-E4F0CFD6-546F-40CD-B612-2CF0C84F77A1Q91562159-9FB5AF66-A089-4E50-B746-371BB235A52BQ91759421-E56BAE45-BF3F-4091-ABD5-F45AAD66DE5AQ92033956-BFE3C7AB-2B44-4734-9DBC-DC8263CCDB11Q92213775-89B1FD4B-3E7E-42EB-9749-A19338FE898BQ92404916-4217D0A5-6CEF-41C9-893D-696DE4C33405Q92534462-9AB44C5C-F995-4F03-8A06-A07FCF87F014Q92571425-8B949142-8BCD-4451-BDCB-9663EC2AC390Q92597556-308A46CF-3708-4B39-A91A-3EA5178E1751Q92696322-C491B0C0-3640-4439-A5A2-E5A9B82717ED
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Matthew T Harting
@en
Matthew T Harting
@nl
type
label
Matthew T Harting
@en
Matthew T Harting
@nl
prefLabel
Matthew T Harting
@en
Matthew T Harting
@nl
P31
P496
0000-0002-8929-8311